Modern Dental Group Announces 2026 Interim Results 
Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth 
Nissin Foods Announces 2026 Interim Results 
The World’s Leading Minds in Biotechnology Will Meet in Riyadh This September 
Overseas Growth Gathers Momentum as CanSinoBIO’s Global Strategy Unlocks New Opportunities CORRECTION: Li-Metal Raises Over $19 Million from the Exercise of Share Purchase Warrants
(This release corrects the release that was posted on December 24, 2021, which incorrectly stated…
EverGrow New Cryptocurrency That Could 100X in 2022
NEWARK, DE / ACCESSWIRE / December 27, 2021 / EverGrow, a newly launched crypto, is…
On substantial participation (4) – specified
On December 27th, 2021 JSC Olainfarm has received specified announcement on substantial participation from AS…
Sosei Heptares to present at 40th Annual J.P. Morgan Healthcare Conference
TOKYO, Japan and LONDON, Dec. 28, 2021 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the Company”;…
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
First subject dosed with Nykode Therapeutics’ T cell focused SARS-CoV-2 vaccine candidate. This is part…
Burning Rock Announces Results of 2021 Annual General Meeting
GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
Eledon Pharmaceuticals to Participate in January 2022 Investor Conferences
IRVINE, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong
Infant Bacterial Therapeutics AB today announces that the Patent Offices of Brazil and Hong Kong…
Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects the Omicron Variant
COVISTIX maintains its ability to detect the Omicron Variant, in addition to detecting SARS-CoV-2 and…
Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista
cPass neutralizing antibody testing seeing increasing demand, questions of infection-acquired immunity, vaccine-acquired immunity and booster…
Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market
SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq:…
Castellum Announces Signing of LOI to Acquire $4 Million Government Contractor
Castellum Announces Signing of LOI to Acquire $4 million government contractor Castellum, Inc. (OTC: ONOV)…
Faraday Pharmaceuticals Announces Publication of Results from its Phase 2 Study of FDY-5301 for the Treatment of Reperfusion Injury Following a STEMI Heart Attack
To be Published in the International Journal of Cardiology SEATTLE, Dec. 27, 2021 (GLOBE NEWSWIRE)…
Revolo Biotherapeutics Announces the Appointment of Tunde Otulana, M.D., to its Board of Directors
NEW ORLEANS and LONDON, Dec. 27, 2021 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
TRACON Pharmaceuticals Announces Positive Results from the Independent Data Monitoring Committee Review of Interim Safety and Efficacy Data from the Ongoing ENVASARC Pivotal Trial
Pre-specified Interim Analysis Concluded with Recommendation to Continue the ENVASARC Trial Objective Response Rate (ORR)…
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
FLORHAM PARK, N.J., Dec. 27, 2021 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference
WAYNE, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19
HAIFA, Israel, Dec. 27, 2021 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) (the “Company”),…
Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potentially Treat and Prevent COVID-19
Pardes Biosciences Main Protease Pardes Biosciences Main Protease PBI-0451 Pardes Biosciences PBI-0451 Oral Antiviral Pill…
BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study
– ATTRibute-CM did not meet its primary endpoint at Month 12. Mean observed six-minute walk…